2019
DOI: 10.1007/978-1-4939-9080-1_9
|View full text |Cite
|
Sign up to set email alerts
|

Induced Neurons for the Study of Neurodegenerative and Neurodevelopmental Disorders

Abstract: Patient-derived or genomically modified human induced pluripotent stem cells (iPSCs) offer the opportunity to study neurodevelopmental and neurodegenerative disorders. Overexpression of certain neurogenic transcription factors (TFs) in iPSCs can induce efficient differentiation into homogeneous populations of the disease-relevant neuronal cell types. Here we provide protocols for genomic manipulations of iPSCs by CRISPR/Cas9. We also introduce two methods, based on lentiviral delivery and the piggyBac transpos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1
1

Relationship

4
3

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 19 publications
0
6
0
Order By: Relevance
“…Previous studies on hiPSC-derived networks were either limited to short-term evaluation of less than a month ( Ronchi et al, 2021 ; Akarca et al, 2022 ) or probing the activity with conventional MEAs with limited number of electrodes ( Odawara et al, 2014 , 2016 ; Hyvärinen et al, 2019 ; Lu et al, 2019 ; Schmieder et al, 2022 ). Here we exploited the advantages of HD-MEAs and our established long-term culturing protocol for hiPSC-derived networks ( Klapper et al, 2017 ; Sauter et al, 2019 ; Schmieder et al, 2022 ) to extract functional and morphological data of developing hiPSC-derived networks for 3 months. We constantly applied astrocyte-conditioned medium to the neuronal cultures to improve their functional maturation ( Klapper et al, 2017 ; Taga et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies on hiPSC-derived networks were either limited to short-term evaluation of less than a month ( Ronchi et al, 2021 ; Akarca et al, 2022 ) or probing the activity with conventional MEAs with limited number of electrodes ( Odawara et al, 2014 , 2016 ; Hyvärinen et al, 2019 ; Lu et al, 2019 ; Schmieder et al, 2022 ). Here we exploited the advantages of HD-MEAs and our established long-term culturing protocol for hiPSC-derived networks ( Klapper et al, 2017 ; Sauter et al, 2019 ; Schmieder et al, 2022 ) to extract functional and morphological data of developing hiPSC-derived networks for 3 months. We constantly applied astrocyte-conditioned medium to the neuronal cultures to improve their functional maturation ( Klapper et al, 2017 ; Taga et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…Human embryonic stem cells (hESCs) ( Ilic & Ogilvie, 2017 ) and human-induced pluripotent stem cells (hiPSCs) ( Hockemeyer & Jaenisch, 2016 ; Shi et al, 2017 ) offer an almost unlimited cell source for neuronal cell and circuit engineering. Many protocols to drive stem cells into neurons require multiple steps and long time periods using soluble factors and specific culturing techniques ( Sauter et al, 2019 ). There exist also single-step differentiation protocols by inducible neurogenic transcription factor expression that result in rapid neurogenesis ( Pang et al, 2011 ; Zhang et al, 2013 ; Busskamp et al, 2014 ).…”
Section: Introductionmentioning
confidence: 99%
“…[75][76][77][78] Disease-causing mutations may also be introduced in iPSCs from healthy individuals by genomic modifications using clustered regularly interspaced short palindromic repeat (CRISPR)-Cas systems, for instance, to derive isogenic backgrounds. [79,80] The identification of genetic variation that predisposes to disease is of tremendous importance when attempting to identify the molecular and cellular underpinnings of a pathological process; [73] in particular when studying genetic variants that only mildly increase disease risk. Hereby, correcting a disease mutation in a patient-derived cell line to the wildtype genotype may be more beneficial for disease modeling since the genetic background is already permissive to disease progression.…”
Section: Modeling Pch2a With Patient-derived Cellsmentioning
confidence: 99%